“Evaluation of the use of CGRP monoclonal antibodies (mAbs) in migraine prophylaxis in a private clinic”, Headache Med, vol. 14, no. 2, pp. 83–88, Jun. 2023, doi: 10.48208/HeadacheMed.2023.17.